- Home
- ELDN vs FCAP Comparison
ELDN vs FCAP Comparison
Compare ELDN & FCAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELDN
- FCAP
- Stock Information
- Founded
- ELDN 2004
- FCAP 1891
- Country
- ELDN United States
- FCAP United States
- Employees
- ELDN N/A
- FCAP N/A
- Industry
- ELDN Biotechnology: Pharmaceutical Preparations
- FCAP Savings Institutions
- Sector
- ELDN Health Care
- FCAP Finance
- Exchange
- ELDN Nasdaq
- FCAP Nasdaq
- Market Cap
- ELDN 140.3M
- FCAP 114.3M
- IPO Year
- ELDN N/A
- FCAP 1999
- Fundamental
- Price
- ELDN $4.07
- FCAP $32.47
- Analyst Decision
- ELDN Strong Buy
- FCAP
- Analyst Count
- ELDN 1
- FCAP 0
- Target Price
- ELDN $16.00
- FCAP N/A
- AVG Volume (30 Days)
- ELDN 1.0M
- FCAP 2.0K
- Earning Date
- ELDN 11-12-2024
- FCAP 10-25-2024
- Dividend Yield
- ELDN N/A
- FCAP 3.48%
- EPS Growth
- ELDN N/A
- FCAP N/A
- EPS
- ELDN N/A
- FCAP 3.52
- Revenue
- ELDN N/A
- FCAP $41,072,000.00
- Revenue This Year
- ELDN N/A
- FCAP N/A
- Revenue Next Year
- ELDN N/A
- FCAP N/A
- P/E Ratio
- ELDN N/A
- FCAP $9.46
- Revenue Growth
- ELDN N/A
- FCAP N/A
- 52 Week Low
- ELDN $1.11
- FCAP $24.40
- 52 Week High
- ELDN $5.54
- FCAP $38.00
- Technical
- Relative Strength Index (RSI)
- ELDN 51.95
- FCAP 35.25
- Support Level
- ELDN $3.76
- FCAP $33.00
- Resistance Level
- ELDN $4.17
- FCAP $35.11
- Average True Range (ATR)
- ELDN 0.39
- FCAP 0.37
- MACD
- ELDN -0.15
- FCAP -0.28
- Stochastic Oscillator
- ELDN 18.45
- FCAP 0.00
About ELDN Eledon Pharmaceuticals Inc.
Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and for patients living with ALS. The company's compound in development is tegoprubart, an IgG1, anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.
About FCAP First Capital Inc.
First Capital Inc is the financial holding company of First Harrison Bank. Through its subsidiary, it operates as a federally-chartered savings bank that provides banking services to individuals and business customers across locations in America. The bank offers various loans which include residential loans, construction loans, commercial real estate loans and commercial business loans. It also provides consumer loans such as home equity and second mortgage loans, and automobile and truck loans.